Abstract
Objective. To analyze the factors influencing quality of acute myocardial infarction, and improve the treatment and management level of the disease. Methods. A total of 226 cases of acute myocardial infarction with disease quality control in 2012 were selected as a control group, and 193 cases of acute myocardial infarction without quality control at the same time in 2011 were selected as a non-control group. The result quality indicators and the link quality indicators were compared and evaluated comprehensively. Results. The rates of serious cases in the control group and the non-control group are the same (P > 0.05). The cure and improvement rate, average length of stay, low density lipoprotein cholesterol assessment, health education and so on of the control group are better than those of the non-control group (P > 0.05). The average cost, drug thrombolysis time, left ventricular function evaluation finishing rate within 24 h of patients having thrombolysis and general treatments are also seen to have been improved. But the difference is not obvious (P > 0.05). Conclusions. We can continue to improve the management quality of acute myocardial infarction diseases by process reengineering, department training, application of clinical pathway, medical record quality control, tracking test, and quality control measures, etc.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
